Induction With Anti-Thymocyte Globulin (r-ATG) and Delayed Calcineurin Inhibitor Therapy in Patients With Acute Renal Failure Dysfunction Pre-Liver Transplant Allows for Sustained Renal Recovery Post Transplant.

被引:0
|
作者
Presser, N. [1 ]
Watson, M. [2 ]
Bollinger, J. [3 ]
Fujiki, M. [1 ]
Diago, T. [1 ]
Aucjeo, F. [1 ]
Quintini, C. [1 ]
Hashimoto, K. [1 ]
Kelly, D. [1 ]
Winans, C. [1 ]
Miller, C. [1 ]
Fung, J. [1 ]
Eghtesad, B. [1 ]
机构
[1] Cleveland Clin, Digest Dis Inst, Cleveland, OH 44106 USA
[2] Cleveland Clin Florida, Weston, FL USA
[3] Cleveland Clin, Dept Pharm, Cleveland, OH 44106 USA
关键词
D O I
10.1097/00007890-201407151-02412
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A428
引用
收藏
页码:709 / 709
页数:1
相关论文
共 25 条
  • [21] IL2R MONOCLONAL ANTIBODY (BASILIXIMAB) AS INDUCTION THERAPY IN IMMUNOSUPPRESSION FOR LIVER TRANSPLANT PATIENTS: A RETROSPECTIVE STUDY FOR RENAL DYSFUNCTION AND ACUTE CELLULAR REJECTION
    Da Silva Amanda Pinter, C.
    Boteon, Yuri Longatto
    Boin, Ilka De Fatima S. F.
    De Ataide, Elaine Cristina
    [J]. TRANSPLANT INTERNATIONAL, 2015, 28 : 735 - 735
  • [22] Long-term outcomes of liver transplantation in patients with pre-transplant renal dysfunction treated with induction therapy and delayed reduced de novo once-daily tacrolimus
    Gastaca, M.
    Bustamante, J.
    Ventoso, A.
    Fernandez, J. R.
    Ruiz, P.
    Palomares, I
    Testillano, M.
    Prieto, M.
    Salvador, P.
    Senosiain, M.
    Suarez, M. J.
    Valdivieso, A.
    [J]. TRANSPLANTATION, 2018, 102 : 247 - 247
  • [23] Long-Term Outcomes of Liver Transplantation in Patients with Pre-Transplant Renal Dysfunction Treated with Induction Therapy and Delayed Reduced De Novo Once-Daily Tacrolimus.
    Gastaca, M.
    Bustamante, J.
    Ventoso, A.
    Fernandez, J.
    Ruiz, P.
    Testillano, M.
    Prieto, M.
    Salvador, P.
    Palomares, I.
    Senosiain, M.
    Suarez, M.
    Valdivieso, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 838 - 838
  • [24] Interleukin-2 receptor alpha sub-unit antibody (IL2Rα-Ab) therapy allows delayed introduction of calcineurin-inhibitor (CI) based immunosuppression in liver transplant patients with perioperative renal impairment (RD).
    Rosser, B
    Mai, M
    Kramer, D
    Grewal, H
    Satyanarayana, R
    Keaveny, A
    Dickson, R
    Harnois, D
    Hewitt, W
    Nguyen, J
    Hughes, C
    Gonwa, T
    Steers, J
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 367 - 367
  • [25] Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
    Nagler, Arnon
    Labopin, Myriam
    Swoboda, Ryszard
    Schroeder, Thomas
    Hamladji, Rose-Marie
    Griskevicius, Laimonas
    Salmenniemi, Urpu
    Rambaldi, Alessandro
    Mielke, Stephan
    Kulagin, Alexander
    Passweg, Jakob
    Luft, Thomas
    Gedde-Dahl, Tobias
    Forcade, Edouard
    Helbig, Grzegorz
    Stelljes, Matthias
    Castilla-Llorente, Cristina
    Spyridonidis, Alexandros
    Brissot, Eolia
    Ciceri, Fabio
    Mohty, Mohamad
    [J]. BONE MARROW TRANSPLANTATION, 2024, 59 (07) : 1012 - 1021